Submit Deal

BIOMAT USA

Summary

Biomat USA operates as a health care company. The Company produce and market life-saving, plasma-derived medicines, diagnostic systems, and hospital pharmacy products, as well as offers medical screening, physical examination, and after care services.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 722 M

Avg. Deal Size£ 722 M

Market Context

Parent Company

GRIFOLS SA

9 transactions

Senior Management

Wada Shinji
CEO

Sort

dechert

HQ - Philadelphia

legal advisors (1)

1 Shared Deal

1 Opposite

£ 722 M

Total Value

garrigues

HQ - Madrid, Spain

legal advisors (1)

1 Shared Deal

1 Opposite

£ 722 M

Total Value

bnp paribas

HQ - Paris

financial advisors (1)

1 Shared Deal

1 For

£ 722 M

Total Value

proskauer rose

HQ - New York

legal advisors (1)

1 Shared Deal

1 For

£ 722 M

Total Value

nomura

HQ - Tokyo

financial advisors (1)

1 Shared Deal

1 Along

£ 722 M

Total Value

osborne clarke

legal advisors (1)

1 Shared Deal

1 Along

£ 722 M

Total Value

white & case

HQ - New York

legal advisors to financial advisors (1)

1 Shared Deal

1 Along

£ 722 M

Total Value

milbank

HQ - New York

legal advisors to debt providers (1)

1 Shared Deal

1 Along

£ 722 M

Total Value

bank of america

HQ - Charlotte

debt providers (1)

1 Shared Deal

1 Along

£ 722 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy